BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24998186)

  • 1. Molecular classification of non-muscle-invasive bladder cancer (pTa low-grade, pT1 low-grade, and pT1 high-grade subgroups) using methylation of tumor-suppressor genes.
    Sacristan R; Gonzalez C; Fernández-Gómez JM; Fresno F; Escaf S; Sánchez-Carbayo M
    J Mol Diagn; 2014 Sep; 16(5):564-572. PubMed ID: 24998186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours.
    Agundez M; Grau L; Palou J; Algaba F; Villavicencio H; Sanchez-Carbayo M
    Eur Urol; 2011 Jul; 60(1):131-40. PubMed ID: 21514719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of a novel panel of tumor suppressor genes in urine moves forward noninvasive diagnosis and prognosis of bladder cancer: a 2-center prospective study.
    García-Baquero R; Puerta P; Beltran M; Alvarez M; Sacristan R; Alvarez-Ossorio JL; Sánchez-Carbayo M
    J Urol; 2013 Aug; 190(2):723-30. PubMed ID: 23485510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplexed methylation profiles of tumor suppressor genes in bladder cancer.
    Cabello MJ; Grau L; Franco N; Orenes E; Alvarez M; Blanca A; Heredero O; Palacios A; Urrutia M; Fernández JM; López-Beltrán A; Sánchez-Carbayo M
    J Mol Diagn; 2011 Jan; 13(1):29-40. PubMed ID: 21227392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors.
    García-Baquero R; Puerta P; Beltran M; Alvarez-Mújica M; Alvarez-Ossorio JL; Sánchez-Carbayo M
    Tumour Biol; 2014 Jun; 35(6):5777-86. PubMed ID: 24577895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.
    Casadio V; Molinari C; Calistri D; Tebaldi M; Gunelli R; Serra L; Falcini F; Zingaretti C; Silvestrini R; Amadori D; Zoli W
    J Exp Clin Cancer Res; 2013 Nov; 32(1):94. PubMed ID: 24252461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyamine-modulated factor-1 methylation predicts Bacillus Calmette-Guérin response in patients with high-grade non-muscle-invasive bladder carcinoma.
    Alvarez-Múgica M; Fernández-Gómez JM; Cebrian V; Fresno F; Escaf S; Sánchez-Carbayo M
    Eur Urol; 2013 Feb; 63(2):364-70. PubMed ID: 22682992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant methylation of tumour suppressor genes WT1, GATA5 and PAX5 in hepatocellular carcinoma.
    Mžik M; Chmelařová M; John S; Laco J; Slabý O; Kiss I; Bohovicová L; Palička V; Nekvindová J
    Clin Chem Lab Med; 2016 Dec; 54(12):1971-1980. PubMed ID: 27171388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
    Yan C; Kim YW; Ha YS; Kim IY; Kim YJ; Yun SJ; Moon SK; Bae SC; Kim WJ
    J Surg Oncol; 2012 Mar; 105(4):425-30. PubMed ID: 22311819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of protocadherin 8 (PCDH8) promoter methylation in non-muscle invasive bladder cancer.
    Lin YL; Wang YL; Ma JG; Li WP
    J Exp Clin Cancer Res; 2014 Aug; 33(1):68. PubMed ID: 25927589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining molecular and pathologic data to prognosticate non-muscle-invasive bladder cancer.
    van Rhijn BW
    Urol Oncol; 2012; 30(4):518-23. PubMed ID: 22742564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of HOXA9 and ISL1 Predicts Patient Outcome in High-Grade Non-Invasive Bladder Cancer.
    Kitchen MO; Bryan RT; Haworth KE; Emes RD; Luscombe C; Gommersall L; Cheng KK; Zeegers MP; James ND; Devall AJ; Fryer AA; Farrell WE
    PLoS One; 2015; 10(9):e0137003. PubMed ID: 26332997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis.
    Friedrich MG; Toma MI; Petri S; Cheng JC; Hammerer P; Erbersdobler A; Huland H
    Eur Urol; 2004 Jun; 45(6):737-43. PubMed ID: 15149745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative genome-wide methylation analysis of high-grade non-muscle invasive bladder cancer.
    Kitchen MO; Bryan RT; Emes RD; Glossop JR; Luscombe C; Cheng KK; Zeegers MP; James ND; Devall AJ; Mein CA; Gommersall L; Fryer AA; Farrell WE
    Epigenetics; 2016 Mar; 11(3):237-46. PubMed ID: 26929985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBC
    Ecke TH; Weiß S; Stephan C; Hallmann S; Arndt C; Barski D; Otto T; Gerullis H
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of the TPEF- and PAX6-promoters is increased in early bladder cancer and in normal mucosa adjacent to pTa tumours.
    Hellwinkel OJ; Kedia M; Isbarn H; Budäus L; Friedrich MG
    BJU Int; 2008 Mar; 101(6):753-7. PubMed ID: 18070176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases.
    Pan CC; Chang YH; Chen KK; Yu HJ; Sun CH; Ho DM
    Am J Clin Pathol; 2010 May; 133(5):788-95. PubMed ID: 20395527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
    Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
    Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
    Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
    Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.